NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $98K of Nuvectis Pharma, Inc.
Bought$98,400
$4.92Price
20,000Shares
+1%Stake
What NVCT did for a copier
- $1,000 copied at Mon, Nov 18 open, $5.00
- $1,078
- S&P 500, same days
- +0.1%
Measured over 30 trading days, to the Jan 2 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +55.4% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Nov 15. Filed Mon, Nov 18, 3:30 AM ET, before the open. Returns use the Nov 18 open and the Jan 2 close. Not investment advice.